Alliancebernstein L.P. Buys 96,727 Shares of UnitedHealth Group (UNH)
Alliancebernstein L.P. lifted its stake in shares of UnitedHealth Group (NYSE:UNH) by 1.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,334,593 shares of the healthcare conglomerate’s stock after purchasing an additional 96,727 shares during the period. UnitedHealth Group accounts for about 1.2% of Alliancebernstein L.P.’s portfolio, making the stock its 8th largest holding. Alliancebernstein L.P. owned approximately 0.76% of UnitedHealth Group worth $1,616,984,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other institutional investors also recently modified their holdings of the company. Lombard Odier Asset Management USA Corp acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $3,585,000. Unio Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $4,471,000. Tiger Eye Capital LLC lifted its holdings in UnitedHealth Group by 36.1% in the fourth quarter. Tiger Eye Capital LLC now owns 92,514 shares of the healthcare conglomerate’s stock valued at $20,396,000 after acquiring an additional 24,514 shares during the last quarter. Pittenger & Anderson Inc. lifted its holdings in UnitedHealth Group by 1.8% in the fourth quarter. Pittenger & Anderson Inc. now owns 28,776 shares of the healthcare conglomerate’s stock valued at $6,344,000 after acquiring an additional 515 shares during the last quarter. Finally, Leucadia National Corp acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $478,000. Institutional investors and hedge funds own 86.78% of the company’s stock.
A number of research analysts recently commented on the company. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $254.00 price objective on the stock. in a report on Friday. Cantor Fitzgerald reiterated a “buy” rating and issued a $280.00 price objective on shares of UnitedHealth Group in a report on Thursday, March 8th. Citigroup upped their price objective on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Oppenheimer upped their price objective on UnitedHealth Group from $260.00 to $240.00 and gave the company an “outperform” rating in a report on Wednesday, January 17th. Finally, Deutsche Bank boosted their target price on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a research report on Wednesday, January 17th. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company. UnitedHealth Group has an average rating of “Buy” and an average target price of $244.62.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping analysts’ consensus estimates of $2.50 by $0.09. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business had revenue of $52.06 billion for the quarter, compared to analyst estimates of $51.57 billion. During the same quarter in the prior year, the company earned $2.11 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. analysts predict that UnitedHealth Group will post 12.52 EPS for the current year.
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 20th. Stockholders of record on Friday, March 9th were given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.30%. The ex-dividend date of this dividend was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 29.79%.
In related news, CEO Steven H. Nelson sold 14,233 shares of the stock in a transaction on Thursday, March 15th. The stock was sold at an average price of $230.22, for a total value of $3,276,721.26. Following the transaction, the chief executive officer now owns 18,219 shares of the company’s stock, valued at $4,194,378.18. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Larry C. Renfro sold 22,184 shares of the stock in a transaction on Thursday, March 15th. The shares were sold at an average price of $228.94, for a total value of $5,078,804.96. Following the completion of the transaction, the insider now directly owns 173,229 shares in the company, valued at approximately $39,659,047.26. The disclosure for this sale can be found here. Insiders have sold 77,015 shares of company stock worth $17,879,199 in the last ninety days. Corporate insiders own 0.89% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This story was first reported by Daily Political and is the property of of Daily Political. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.dailypolitical.com/2018/04/17/alliancebernstein-l-p-buys-96727-shares-of-unitedhealth-group-unh.html.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.